ACTRN12612000261819CompletedPhase 2
Pilot Study of the Effects of GC811007 Administration on Copper and Trace Metal Metabolism in Non-diabetic Subjects and Patients with Type 2 Diabetes Mellitus: A Dose-response Sub-study of TETA on urinary copper excretion
Protemix Corporation Ltd.0 sites14 target enrollmentStarted: March 2, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 14
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Treatment
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- o limit to o limit (—)
- Sex
- Male
Inclusion Criteria
- •Patients with type-2 diabetes mellitus and healthy non-diabetic subjects with normal glucose tolerance; normal ECG; normal serum levels of Fe and ferritin
Exclusion Criteria
- •Subjects who had not participated in a previous 12-day residential study of trace metal balance; eligible subjects who did not have normal glucose tolerance and ECG and normal levels of serum Fe and Ferritin
Investigators
Similar Trials
Completed
Phase 2
Pilot Study of the Effects of GC811007 Administration on Copper and Trace Metal Metabolism in Non-diabetic Subjects and Patients with Type 2 Diabetes MellitusMetabolic and Endocrine - DiabetesType 2 Diabetes MellitusACTRN12612000293864Protemix Corporation40
Completed
Phase 2
Inhibition of Fructosamine Oxidase in Diabetic Nephropathy (INFO-Renal) StudyACTRN12612000959875Protemix Corporation, Ltd.120
Active, not recruiting
Phase 1
Research study investigating how well NNC0174-0833 works in people suffering from overweight or obesityEUCTR2018-001945-14-FIovo Nordisk A/S700
Active, not recruiting
Phase 1
Research study investigating how well NNC0174-0833 works in people suffering from overweight or obesityObesityOverweightMedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10033307Term: OverweightSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2018-001945-14-PLovo Nordisk A/S700
Active, not recruiting
Phase 1
Research study investigating how well NNC0174-0833 works in people suffering from overweight or obesityEUCTR2018-001945-14-GBovo Nordisk A/S700